Cascadian Therapeutics Inc. (CASC): Seth Klarman Took A Victory Lap

Value investor Seth Klarman disclosed in a recent 13G filing that it tendered all of its 8.7 million stake in Cascadian Therapeutics Inc. (CASC).

Keep Reading →